Paul Tudor Jones's MMSI Position Overview
Paul Tudor Jones (via Tudor Investment Corp Et Al) currently holds 35 M shares of Merit Medical Systems, Inc. (MMSI) worth $40.86 M, representing 0.07% of the portfolio. First purchased in 2013-Q4, this long-term strategic position has been held for 48 quarters.
Based on 13F filings since 2013, Paul Tudor Jones has maintained a long-term strategic position in MMSI, representing a significant commitment to this investment thesis. Largest addition occurred in Q3 2025, adding 34.85 M shares. Largest reduction occurred in Q2 2017, reducing 79,163 shares.
Analysis based on 13F filings available since 2013 Q2
Paul Tudor Jones's Merit Medical Systems (MMSI) Holding Value Over Time
Track share changes against reported price movement
Quarterly Merit Medical Systems (MMSI) Trades by Paul Tudor Jones
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2013 | +29,349 | New Buy | 29,349 | $15.74 |
| Q1 2014 | +9,150 | Add 31.18% | 38,499 | $14.31 |
| Q2 2014 | +10,768 | Add 27.97% | 49,267 | $15.10 |
| Q3 2014 | +2,825 | Add 5.73% | 52,092 | $11.88 |
| Q4 2014 | -39,251 | Reduce 75.35% | 12,841 | $17.37 |
| Q1 2015 | +17,892 | Add 139.33% | 30,733 | $19.26 |
| Q2 2015 | +1,204 | Add 3.92% | 31,937 | $21.54 |
| Q3 2015 | +2,238 | Add 7.01% | 34,175 | $23.91 |
| Q4 2015 | -2,430 | Reduce 7.11% | 31,745 | $18.59 |
| Q1 2016 | -31,745 | Sold Out | 31,745 | $0.00 |
| Q2 2016 | +12,139 | New Buy | 12,139 | $19.85 |
| Q3 2016 | -425 | Reduce 3.50% | 11,714 | $24.33 |
| Q4 2016 | -11,714 | Sold Out | 11,714 | $0.00 |
| Q1 2017 | +85,779 | New Buy | 85,779 | $28.90 |
| Q2 2017 | -79,163 | Reduce 92.29% | 6,616 | $38.09 |
| Q3 2017 | -6,616 | Sold Out | 6,616 | $0.00 |
| Q1 2018 | +4,789 | New Buy | 4,789 | $45.31 |
| Q2 2018 | -4,789 | Sold Out | 4,789 | $0.00 |
| Q2 2020 | +6,793 | New Buy | 6,793 | $45.64 |
| Q3 2020 | +36,074 | Add 531.05% | 42,867 | $43.51 |
| Q4 2020 | -24,683 | Reduce 57.58% | 18,184 | $55.49 |
| Q1 2021 | -18,184 | Sold Out | 18,184 | $0.00 |
| Q4 2021 | +28,075 | New Buy | 28,075 | $62.30 |
| Q1 2022 | -10,705 | Reduce 38.13% | 17,370 | $66.49 |
| Q2 2022 | +4,213 | Add 24.25% | 21,583 | $54.26 |
| Q3 2022 | -21,583 | Sold Out | 21,583 | $0.00 |
| Q2 2023 | +38,357 | New Buy | 38,357 | $83.64 |
| Q3 2023 | -1,189 | Reduce 3.10% | 37,168 | $69.02 |
| Q4 2023 | +41,669 | Add 112.11% | 78,837 | $75.96 |
| Q1 2024 | -78,837 | Sold Out | 78,837 | $0.00 |
| Q2 2024 | +52,793 | New Buy | 52,793 | $85.95 |
| Q3 2024 | +68,229 | Add 129.24% | 121,022 | $98.83 |
| Q4 2024 | +25,645 | Add 21.19% | 146,667 | $96.72 |
| Q1 2025 | -146,667 | Sold Out | 146,667 | $0.00 |
| Q3 2025 | +35 M | New Buy | 35 M | $1.17 |
Paul Tudor Jones's Merit Medical Systems Investment FAQs
Paul Tudor Jones first purchased Merit Medical Systems, Inc. (MMSI) in Q4 2013, acquiring 29,349 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones has held Merit Medical Systems, Inc. (MMSI) for 48 quarters since Q4 2013. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's largest addition to Merit Medical Systems, Inc. (MMSI) was in Q3 2025, adding 35,000,000 shares worth $40.86 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
According to the latest 13F filing for Q3 2025, Paul Tudor Jones's firm, Tudor Investment Corp Et Al, owns 35,000,000 shares of Merit Medical Systems, Inc. (MMSI), valued at approximately $40.86 M. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
As of the Q3 2025 filing, Merit Medical Systems, Inc. (MMSI) represents approximately 0.07% of Paul Tudor Jones's publicly disclosed stock portfolio, making it one of their key holdings. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Paul Tudor Jones's peak holding in Merit Medical Systems, Inc. (MMSI) was 35,000,000 shares, as reported at the end of Q3 2025. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.